PLATELET-RICH PLASMA INJECTION THERAPY FOR REFRACTORY COCCYDYNIA: A CASE SERIES

Fergie-Ross L. Montero-Cruz
{"title":"PLATELET-RICH PLASMA INJECTION THERAPY FOR REFRACTORY COCCYDYNIA: A CASE SERIES","authors":"Fergie-Ross L. Montero-Cruz","doi":"10.36076/pmcr.2018/2/183","DOIUrl":null,"url":null,"abstract":"Background: Coccydynia is pain in the coccyx\nregion. The most common cause of coccydynia\nis trauma, either from a direct axial force such\nas during a fall onto the coccyx or from cumulative\ntrauma as a result of poor sitting mechanics.\nRisk factors include obesity, female gender and\nrapid weight loss. The anatomy of the region is\nnot well vascularized, and consists of the coccyx\nbones, and supporting ligaments and tendons.\nFor a majority of patients, conservative management\nmay be successful but for the remainder\nof patients, pain relief may only be transient and\npain can become debilitating. What has yet to be\nfully explored is the possible beneficial effect of\nlocal injection of platelet-rich plasma (PRP) for\nthe treatment of refractory coccydynia. PRP injections\nhave been successful in treating a variety\nof chronic tendon, ligament and bone injuries by\ninducing an inflammatory response to promote or\nre-initiate healing. In addition, local injections of\nPRP to the coccyx would be a less invasive option\nthan surgery for patients who have exhausted all\nother treatment options and continue to struggle\nwith the debilitating effects of coccydynia.\nObjectives: To demonstrate the important role\nof PRP therapy in treating coccydynia refractory\nto traditional conservative management.\nStudy Design: Retrospective case series.\nMethods: Three patients with coccygeal pain\nfor greater than 6 months who presented to an\noutpatient pain management office in New York\nfrom 2014 until 2016, and failed conventional\ntreatments. When the pain was deemed refractory\nfor the patient, offering for PRP was done.\nThis was presented with the option to repeat once\nagain at the 6-8 week mark if needed. All patients\nunderwent PRP with fluoroscopic injection, and\nthe use of the same PRP commercially available\nsystem; Magellan-Arteriocyte. The patients were\nevaluated with a numerical rating scale, and percentage\nof pain relief at 6-8 week post-injection, 6\nmonths post-injection, 12 months post-injection,\nand 24 months post-injection was recorded.\nPercentage of pain relief was then calculated.\nResults: Overall the patient series demonstrated\nsignificant improvement in numeric pain scale, as\nwell as percentage of pain reduction. At the 6-8\nweek follow-up for all the post-PRP injections,\nthere was an average of 75% improvement in\noverall pain. At 6 months, 1 patient had no change,\nwhile 2 patients maintained the same reduction\nin pain at the 12- and 24-month follow-ups.\nLimitations: This retrospective case\nseries is only a small sample size of pat\ni e n t s w i t h r e f r a c t o r y c o c c y d y n i a .\nConclusions: Here we discuss the first case\nseries of PRP for coccydynia. The results of the\n3 patients in this case series are encouraging.","PeriodicalId":110696,"journal":{"name":"Pain Management Case Reports","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain Management Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36076/pmcr.2018/2/183","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background: Coccydynia is pain in the coccyx region. The most common cause of coccydynia is trauma, either from a direct axial force such as during a fall onto the coccyx or from cumulative trauma as a result of poor sitting mechanics. Risk factors include obesity, female gender and rapid weight loss. The anatomy of the region is not well vascularized, and consists of the coccyx bones, and supporting ligaments and tendons. For a majority of patients, conservative management may be successful but for the remainder of patients, pain relief may only be transient and pain can become debilitating. What has yet to be fully explored is the possible beneficial effect of local injection of platelet-rich plasma (PRP) for the treatment of refractory coccydynia. PRP injections have been successful in treating a variety of chronic tendon, ligament and bone injuries by inducing an inflammatory response to promote or re-initiate healing. In addition, local injections of PRP to the coccyx would be a less invasive option than surgery for patients who have exhausted all other treatment options and continue to struggle with the debilitating effects of coccydynia. Objectives: To demonstrate the important role of PRP therapy in treating coccydynia refractory to traditional conservative management. Study Design: Retrospective case series. Methods: Three patients with coccygeal pain for greater than 6 months who presented to an outpatient pain management office in New York from 2014 until 2016, and failed conventional treatments. When the pain was deemed refractory for the patient, offering for PRP was done. This was presented with the option to repeat once again at the 6-8 week mark if needed. All patients underwent PRP with fluoroscopic injection, and the use of the same PRP commercially available system; Magellan-Arteriocyte. The patients were evaluated with a numerical rating scale, and percentage of pain relief at 6-8 week post-injection, 6 months post-injection, 12 months post-injection, and 24 months post-injection was recorded. Percentage of pain relief was then calculated. Results: Overall the patient series demonstrated significant improvement in numeric pain scale, as well as percentage of pain reduction. At the 6-8 week follow-up for all the post-PRP injections, there was an average of 75% improvement in overall pain. At 6 months, 1 patient had no change, while 2 patients maintained the same reduction in pain at the 12- and 24-month follow-ups. Limitations: This retrospective case series is only a small sample size of pat i e n t s w i t h r e f r a c t o r y c o c c y d y n i a . Conclusions: Here we discuss the first case series of PRP for coccydynia. The results of the 3 patients in this case series are encouraging.
富血小板血浆注射治疗难治性尾骨痛:一个病例系列
背景:尾骨痛是发生在尾骨区的疼痛。尾骨动力损伤最常见的原因,要么是直接的轴向力,如在跌倒到尾骨上,要么是由于坐位力学不良造成的累积性创伤。危险因素包括肥胖、女性和体重迅速下降。该区域的解剖结构没有很好的血管化,由尾骨、支撑韧带和肌腱组成。对于大多数患者,保守治疗可能是成功的,但对于其余患者,疼痛缓解可能只是短暂的,疼痛可能变得虚弱。局部注射富血小板血浆(PRP)治疗难治性尾骨痛的可能有益效果尚未得到充分探讨。PRP注射通过诱导炎症反应来促进或重新启动愈合,已经成功地治疗了各种慢性肌腱、韧带和骨损伤。此外,对于那些已经用尽所有其他治疗方法并继续与尾骨痛的衰弱效应作斗争的患者来说,在尾骨局部注射prp是一种比手术侵入性更小的选择。目的:探讨PRP治疗传统保守治疗难治性尾骨痛的重要作用。研究设计:回顾性病例系列。方法:2014年至2016年在纽约的一家门诊疼痛管理办公室就诊的3例尾骨疼痛超过6个月的患者,常规治疗失败。当认为疼痛对患者来说是难治性的,提供PRP。如果需要,可以选择在6-8周时再次重复。所有患者均在透视下注射PRP,并使用相同的市售PRP系统;Magellan-Arteriocyte。采用数值评定量表对患者进行评估,记录注射后6-8周、注射后6个月、注射后12个月和注射后24个月疼痛缓解百分比。然后计算疼痛缓解的百分比。结果:总体而言,患者系列在数字疼痛量表以及疼痛减轻百分比方面表现出显着改善。在所有prp注射后的6-8周随访中,总体疼痛平均改善了75%。在6个月时,1例患者没有变化,而2例患者在12个月和24个月的随访中保持相同的疼痛减轻。局限性:本回顾性病例系列仅为一小部分患者的样本量,但其研究结果表明,该研究是一项研究,该研究是一项针对尾骨痛患者进行PRP治疗的研究。本病例系列中的3例患者的结果令人鼓舞。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信